Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 58.81% is 11% below its 5-year average of 66.27%, around the middle of its 5-year range (40.86%–82.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.23% below its 12-month average of 60.77%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 58.81%.
DEBT TO ASSETS RATIO
58.81%
DEBT TO ASSETS RATIO AVG TTM
60.77%
DEBT TO ASSETS RATIO AVG 3Y
72.08%
DEBT TO ASSETS RATIO AVG 5Y
66.27%
DEBT TO ASSETS RATIO AVG 10Y
41.07%
DEBT TO ASSETS RATIO AVG 15Y
28.07%
DEBT TO ASSETS RATIO AVG 20Y
21.14%
CURRENT VS TTM AVG
-3.23%
CURRENT VS 3Y AVG
-18.41%
CURRENT VS 5Y AVG
-11.26%
CURRENT VS 10Y AVG
+43.20%
CURRENT VS 15Y AVG
+109.50%
CURRENT VS 20Y AVG
+178.18%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
+58709.49%
vs the sector median at left
Heron Therapeutics, Inc.
Market Cap
$65.19M
Debt to Assets Ratio
58.81%
TTM Avg
60.77%
3Y Avg
72.08%
5Y Avg
66.27%
Market Cap
$63.78M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$63.30M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.08M
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.42M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | $65.19M | 58.81% | 60.77% | 72.08% | 66.27% |
| Cingulate Inc. (CING)vs › | $65.41M | 0.19% | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $64.68M | 0.27% | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.93M | 0.51% | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.15% | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.30M | 0.01% | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $63.23M | 0.08% | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $68.08M | 0.33% | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.42M | 0.20% | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $61.52M | 0.50% | N/A | N/A | N/A |
Debt/Assets
58.8%
Debt/Equity
21.48
Current Ratio
2.49
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 58.81% |
| 2026-03-31 | 57.52% |
| 2025-12-31 | 54.96% |
| 2025-09-30 | 56.41% |
| 2025-06-30 | 76.15% |
| 2025-03-31 | 75.19% |
| 2024-12-31 | 76.25% |
| 2024-09-30 | 80.74% |
| 2024-06-30 | 81.93% |
| 2024-03-31 | 82.23% |
| 2023-12-31 | 80.73% |
| 2023-09-30 | 78.53% |
| 2023-06-30 | 77.59% |
| 2023-03-31 | 71.05% |
| 2022-12-31 | 62.75% |
| 2022-09-30 | 58.10% |
| 2022-06-30 | 64.97% |
| 2022-03-31 | 58.09% |
| 2021-12-31 | 52.17% |
| 2021-09-30 | 46.68% |
| 2021-06-30 | 40.86% |
| 2021-03-31 | 7.86% |
| 2020-12-31 | 6.96% |
| 2020-09-30 | 6.37% |
| 2020-06-30 | 5.80% |
| 2020-03-31 | 5.30% |
| 2019-12-31 | 3.86% |
| 2019-09-30 | 4.98% |
| 2019-06-30 | 4.39% |
| 2019-03-31 | 4.26% |
| 2018-12-31 | 0.99% |
| 2018-09-30 | 0.92% |
| 2018-06-30 | 5.70% |
| 2018-03-31 | 15.76% |
| 2017-12-31 | 12.24% |
| 2017-09-30 | 24.10% |
| 2017-06-30 | 19.87% |
| 2017-03-31 | 28.01% |
| 2016-12-31 | 78.41% |
| 2016-09-30 | 53.37% |
| 2016-06-30 | 2.98% |
| 2016-03-31 | 2.14% |
| 2015-12-31 | 1.61% |
| 2015-09-30 | 1.30% |
| 2015-06-30 | 1.08% |
| 2015-03-31 | 2.93% |
| 2014-12-31 | 2.08% |
| 2014-09-30 | 1.57% |
| 2014-06-30 | 1.20% |
| 2014-03-31 | 1.85% |
| 2013-12-31 | 1.35% |
| 2013-09-30 | 3.37% |
| 2013-06-30 | 1.98% |
| 2013-03-31 | 1.27% |
| 2012-12-31 | 0.88% |
| 2012-09-30 | 0.65% |
| 2012-06-30 | 1.68% |
| 2012-03-31 | 0.67% |
| 2011-12-31 | 0.53% |
| 2011-09-30 | 0.29% |
| 2011-06-30 | 0.11% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
